EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Experience With Performing Rheocarna Therapy via the Single‐Needle Method for Treatment of Chronic Limb‐Threatening Ischemia

Yasutaka Yamauchi, Rie Tanaka, Reona Kawahira, Shingo Nabeta, Kouhei Naoi, Kazuhito Kitajima, Akira Wada, Tomonari Takagi, Norihiko Ohura iD, Akira Miyamoto

Therapeutic Apheresis and Dialysis · 2026-12 · 30 (6) · 847-853

DOI: 10.1002/1744-9987.70161 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Therapeutic Apheresis and Dialysis, online erschienen am 09.06.2026. Verfasst von Yasutaka Yamauchi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Cardiovascular Center, Takatsu General Hospital, Kawasaki, Kanagawa, Japan. Hauptthemen laut MEDLINE: Ischemia, Blood Component Removal, Chronic Limb-Threatening Ischemia. Die Arbeit nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

This study investigated the safety and efficacy of single‐needle Rheocarna therapy for chronic limb‐threatening ischemia (CLTI) with wounds.

Methods

Six patients with CLTI involving ulcers unresponsive to revascularization underwent single‐needle Rheocarna treatment. Changes in mean low‐density lipoprotein cholesterol (LDL‐C), fibrinogen, C‐reactive protein (CRP), white blood cell (WBC) count, platelet count, blood flow, and wound improvement were compared between treatment initiation and completion.

Results

The treatment never required discontinuation due to in‐circuit coagulation or hypotension, and its safety was confirmed. After 10 treatment sessions, LDL‐C and fibrinogen removal rates were 24.3% and 24.4%, respectively. Platelet, WBC, and CRP values did not change significantly over time. Blood flow increased during treatment and posttreatment. All patients experienced wound improvement and favorable clinical outcomes.

Conclusion

Single‐needle Rheocarna therapy is effective for wound healing in CLTI. If this method applies to nondialysis patients without arteriovenous fistulas, indications for Rheocarna therapy will likely expand.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

IschemiaBlood Component RemovalChronic Limb-Threatening IschemiaHumansFemaleMaleWound HealingAgedTreatment OutcomeNeedlesAged, 80 and overChronic DiseaseFibrinogenCholesterol, LDLC-Reactive ProteinMiddle Aged

Stichwörter der Autor:innen

blood component removalchronic limb‐threatening ischemiahemorheologylipoprotein apheresis

Substanzen

FibrinogenCholesterol, LDLC-Reactive Protein

Autor:innen und Institutionen

  • Cardiovascular Center, Takatsu General Hospital, Kawasaki, Kanagawa, Japan.
  • Department of Cardiology, Tokyo Heart Center, Osaki Hospital, Tokyo, Japan.
  • Department of Clinical Engineer, Takatsu General Hospital, Kawasaki, Kanagawa, Japan.
  • Department of Clinical Engineer, Tokyo Heart Center, Osaki Hospital, Tokyo, Japan.
  • Department of Cardiology, Tokyo Kamata Hospital, Tokyo, Japan.
  • Department of Plastic and Reconstructive Surgery, Kyorin University Hospital, Tokyo, Japan.

ORCID-Profile: Norihiko Ohura

Zitieren

APA

Yamauchi, Y., Tanaka, R., Kawahira, R., Nabeta, S., Naoi, K., Kitajima, K., Wada, A., Takagi, T., Ohura, N., & Miyamoto, A. (2026). Experience With Performing Rheocarna Therapy via the Single‐Needle Method for Treatment of Chronic Limb‐Threatening Ischemia. Therapeutic Apheresis and Dialysis, 30(6), 847-853. https://doi.org/10.1002/1744-9987.70161

Vancouver

Yamauchi Y, Tanaka R, Kawahira R, Nabeta S, Naoi K, Kitajima K, et al. Experience With Performing Rheocarna Therapy via the Single‐Needle Method for Treatment of Chronic Limb‐Threatening Ischemia. Therapeutic Apheresis and Dialysis. 2026;30(6):847-853. doi:10.1002/1744-9987.70161

BibTeX
@article{Yamauchi2026,
  author = {Yamauchi, Yasutaka and Tanaka, Rie and Kawahira, Reona and Nabeta, Shingo and Naoi, Kouhei and Kitajima, Kazuhito and Wada, Akira and Takagi, Tomonari and Ohura, Norihiko and Miyamoto, Akira},
  title = {Experience With Performing Rheocarna Therapy via the Single‐Needle Method for Treatment of Chronic Limb‐Threatening Ischemia},
  journal = {Therapeutic Apheresis and Dialysis},
  year = {2026},
  volume = {30},
  number = {6},
  pages = {847--853},
  doi = {10.1002/1744-9987.70161}
}
Kostenlos starten →